NanoString Technologies, Inc. (NSTG)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

14.23

+0.73

(+5.41%)

At close: 04:00PM EDT

14.23

0.00

(0.00%)

After hours:

05:00PM EDT

Advertisement

A
Strong support around 19.23, but who knows
Neutral
n
They always miss est. No new news
Neutral
k
Don't like this company. I went to the annual meeting as a shareholder. They gave me the run-around like I had leprosy. Lied about the situation. That was years ago. Sold and never bought another share.
J
Buy buy buy. Cant beat this price at 22s. Load it up. Warn you shorts
N
Well that's a spirit breaker, this is going down to $0.0 at this rate. How could it lose over 50% of its value and still be losing more value???? Are people really taking a 50% loss because NanoString came out and said that they made mistakes this quarter? The price hasn't been this low in over three years !
K
More insider selling and downgrades
R
Sales far exceed manufacturing output now, I live locally so there is tons of local news on it, trust me, this market cap is heading to 10B in 3-5 years. buy and hold.
Bullish
Y
NanoString reached a 52 Week low at 20.26
I
stock offering 5m shares at 22dollars ? What is the company going to do with 100 m Dollars. ?
C
NanoString is a five bagger in five years. At least 1% allocation in Roth/IRA.
Bullish
G
I have one question: When do they expect to be PROFITABLE? That is the main reason for going into business, right? How many years can they lose more than they earn before people give up on reaching the carrot of net EPS that never seems to be reachable?
J
Company's technology is really fundamental to evolving genomics. I think it gets bought out, eventually. BRKR, maybe. Who knows.
W
It is what I love about owning NanoString. All-time high and the only poster besides me is a non-sentient one. At least I think I am sentient.
Bullish
I
107.85% institutional ownership?
A
Time for buying dip! They have nice products. The market is there. Hold long.
Bullish
W
Listened to entire conference call. I have owned NSTG as a core position since the spring of 2015; and have listened to a number of the cc's over the years. This call had one of the most bullish tones I have ever heard from NanoString. I just wished i owned a bigger long swing trade into earnings.
b
Nektar Therapeutics used NanoString assays* to characterize the therapeutic activity of NKTR-214, their pegylated IL-2 drug that promotes expansion and activation of cytolytic CD8 T cells, Th1 CD4 T cells and NK cells without inducing activity of regulatory T cells. They used NanoString to observe transcriptional changes within the tumor that were associated with T cell receptor signaling, cytokine mediated signaling, and NK cell activity. NKTR-214 not only induced T cell activation but also upregulated immune checkpoint molecules, suggesting potential combination immunotherapies. NKTR-214 was also evaluated in combination with nivolumab in late stage melanoma, renal cell carcinoma and non-small cell lung cancer. These clinical results were impressive, inducing objective responses in 46-75% of patients, depending on indication, with no additional toxicities induced by the combination therapy.
J
pure speculation here, ILMN tried to buy SGEN but dropped it due to anti-trust concerns. This tells us ILMN is shopping and has plenty of cash - market cap for SGEN is ~$20B. NSTG could be a good fit for ILMN and probably pick it up for 10% of cost for SGEN.

like I say, just speculating...
J
According to Nasdaq, Fidelity increased NSTG holdings in Q2 by 88% - they are the largest shareholder followed by Morgan Stanley and Blackrock and the both increased their holdings also.
W
What a recovery! I imagine they wiped a few traders' stops out with that opening minute downdraft. Today's action bodes well for NanoString investors going forward.